"zycov-d"

MoHFW may approve Covid vaccine this month for those aged between 12 years and 18 years

Nod for Zydus Cadila'd Covid vaccine for children will help India ramp up its vaccination programme quickly

At least four to five more candidates in advanced stages of clinical trials and expected to get a nod from regulatory authorities

The Nation's first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for the conduct of the Phase III clinical trials

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August.

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.

Zydus Cadila had announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D was over and it has commenced phase-II clinical trials from August.